Cargando…

Multimodal Treatment Patterns for Osteoarthritis and Their Relationship to Patient-Reported Pain Severity: A Cross-Sectional Survey in the United States

PURPOSE: The purpose of this study was to assess how patient-reported pain is related to osteoarthritis (OA) treatment patterns in routine clinical practice. PATIENTS AND METHODS: Data were collected between February and May 2017 from 153 United States (US) primary care physicians, rheumatologists,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalamachu, Srinivas R, Robinson, Rebecca L, Viktrup, Lars, Cappelleri, Joseph C, Bushmakin, Andrew G, Tive, Leslie, Mellor, Jennifer, Hatchell, Niall, Jackson, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767791/ https://www.ncbi.nlm.nih.gov/pubmed/33380823 http://dx.doi.org/10.2147/JPR.S285124

Ejemplares similares

Satisfaction with Medications Prescribed for Osteoarthritis: A Cross-Sectional Survey of Patients and Their Physicians in the United States
por: Robinson, Rebecca L., et al.
Publicado: (2022)

Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and Satisfaction
por: Schnitzer, Thomas J., et al.
Publicado: (2023)

Factors associated with physician-reported treatment status of patients with osteoarthritis pain
por: Schnitzer, Thomas J., et al.
Publicado: (2022)

Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic Surgeons
por: Schnitzer, Thomas J., et al.
Publicado: (2023)

Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis”
por: Tive, Leslie A., et al.
Publicado: (2018)

Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety
por: Schmelz, Martin, et al.
Publicado: (2019)

Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis
por: Garrison, Louis P., et al.
Publicado: (2021)

Nerve Growth Factor Signaling and Its Contribution to Pain
por: Barker, Philip A, et al.
Publicado: (2020)

Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity
por: Sadosky, Alesia B, et al.
Publicado: (2010)

Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries
por: Perrot, Serge, et al.
Publicado: (2021)

Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials
por: Berenbaum, Francis, et al.
Publicado: (2021)

Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysis
por: Walsh, David A., et al.
Publicado: (2022)

Examining the Relationships Among Treatment, Pain, and Physical Function in Patients With Osteoarthritis: A Mediation-Modeling Approach
por: Abraham, Lucy, et al.
Publicado: (2023)

An Evaluation of Total Disintegration Time for Three Different Doses of Sublingual Fentanyl Tablets in Patients with Breakthrough Pain
por: Nalamachu, Srinivas
Publicado: (2013)

Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain
por: van Seventer, Robert, et al.
Publicado: (2011)

Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
por: Tive, Leslie, et al.
Publicado: (2019)

Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study
por: Schaefer, Caroline, et al.
Publicado: (2014)

Efficacy and Safety of Cryoneurolysis for Treatment of Chronic Head Pain Secondary to Occipital Neuralgia: A Pilot Study
por: Grigsby, Eric, et al.
Publicado: (2021)

Moderate to Severe Osteoarthritis Pain and Its Impact on Patients in the United States: A National Survey
por: Schepman, Patricia, et al.
Publicado: (2021)

Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab
por: Hunter, D.J., et al.
Publicado: (2022)

Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?
por: Kern, Kai-Uwe, et al.
Publicado: (2013)

Opioid rotation with extended-release opioids: where should we begin?
por: Nalamachu, Srinivas
Publicado: (2011)

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
por: Berenbaum, Francis, et al.
Publicado: (2021)

Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis
por: Conaghan, Philip G., et al.
Publicado: (2022)

Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
por: Kristensen, Lars Erik, et al.
Publicado: (2023)

Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin
por: Shaparin, Naum, et al.
Publicado: (2015)

The Burden of Pain Associated with Osteoarthritis in the Hip or Knee from the Patient’s Perspective: A Multinational Cross-Sectional Study
por: Jackson, James, et al.
Publicado: (2020)

Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States
por: Parsons, Bruce, et al.
Publicado: (2013)

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
por: de Vlam, Kurt, et al.
Publicado: (2021)

Characteristics of Analgesic Patch Formulations
por: Nalamachu, Srinivas, et al.
Publicado: (2020)

Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain
por: Hale, Martin E, et al.
Publicado: (2013)

A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
por: Nalamachu, Srinivas, et al.
Publicado: (2014)

Burden of Illness Associated with Peripheral and Central Neuropathic Pain among Adults Seeking Treatment in the United States: A Patient-Centered Evaluation
por: Schaefer, Caroline, et al.
Publicado: (2014)

Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia
por: Brümmendorf, Tim H., et al.
Publicado: (2020)

Diagnosing and Managing Postherpetic Neuralgia
por: Nalamachu, Srinivas, et al.
Publicado: (2012)

Physician and patient perceptions of surgical procedures for osteoarthritis of the knee in the United States, Europe, and Japan: results of a real-world study
por: Fukui, N, et al.
Publicado: (2022)

The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey
por: DiBonaventura, Marco D, et al.
Publicado: (2017)

Pain Treatment in Arthritis-Related Pain: Beyond NSAIDs
por: van Laar, Mart, et al.
Publicado: (2012)

Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565)
por: Nalamachu, Srinivas, et al.
Publicado: (2020)

Structural and Functional Abnormalities in Knee Osteoarthritis Pain Revealed With Multimodal Magnetic Resonance Imaging
por: Guo, Hua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6dbdvh0ub0a50ecmnp8sahqk5r